Morales-Medina J. C., Juarez I., Venancio-Garcia E., Cabrera S. N., Menard C., Yu W., Flores G., Mechawar N., Quirion R. (2013). Impaired structural hippocampal plasticity is associated with emotional and memory deficits in the olfactory bulbectomized rat, Neuroscience. En savoir plus.

Nazeri A., Chakravarty M., Felsky D., Lobaugh N. J., Rajji T. K., Mulsant B. H., Voineskos A. N. (2013). Alterations of superficial white matter in schizophrenia and relationship to cognitive performance, Neuropsychopharmacology, 38(10), 1954-62. En savoir plus.

Palmour N., Vanderbyl B. L., Zimmerman E., Gauthier S., Racine E. (2013). Alzheimer's Disease Dietary Supplements in Websites, HEC Forum. En savoir plus.

Papadopoulos P., Rosa-Neto P., Rochford J., Hamel E. (2013). Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-beta and cerebrovascular pathology, PLoS One, 8(7), e68612. En savoir plus.

Parent M. J., Bedard M. A., Aliaga A., Minuzzi L., Mechawar N., Soucy J. P., Schirrmacher E., Kostikov A., Gauthier S., Rosa-Neto P. (2013). Cholinergic Depletion in Alzheimer's Disease Shown by [(18) F]FEOBV Autoradiography, Int J Mol Imaging, 2013, 205045. En savoir plus.

Parent M. J., Cyr M., Aliaga A., Kostikov A., Schirrmacher E., Soucy J. P., Mechawar N., Rosa-Neto P., Bedard M. A. (2013). Concordance between in vivo and postmortem measurements of cholinergic denervation in rats using PET with [18F]FEOBV and choline acetyltransferase immunochemistry, EJNMMI Res, 3(1), 70. En savoir plus.

Patterson C., Gauthier S. (2013). Diagnosis and treatment of dementia: the fourth canadian consensus conference, Alzheimers Res Ther, 5(Suppl 1), S1. En savoir plus.

Peters M. E., Rosenberg P. B., Steinberg M., Norton M. C., Welsh-Bohmer K. A., Hayden K. M., Breitner J., Tschanz J. T., Lyketsos C. G., Cache County Investigators (2013). Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study, Am J Geriatr Psychiatry, 21(11), 1116-24. En savoir plus.

Poirier J., Gauthier S. (2013). Ich habe mich selbst verloren, .

Pruessner M., Bechard-Evans L., Boekestyn L., Iyer S.N., Pruessner J., Malla A. (2013). Attenuated cortisol response to acute psychosocial stress in individuals at ultra-high risk for psychosis, Schizophr Res, 146(1-3), 79-86. En savoir plus.

Pruessner M., Vracotas N., Joober R., Pruessner J., Malla A. (2013). Blunted cortisol awakening response in men with first episode psychosis: relationship to parental bonding, Psychoneuroendocrinology, 38(2), 229-40. En savoir plus.

Quirion R., Brière R. (2013). Génomique, épigénomique et troubles de santé mentale, , 3, 11-15.

Reckess G. Z., Brandt J., Luis C. A., Zandi P., Martin B., Breitner J. (2013). Screening by telephone in the Alzheimer's disease anti-inflammatory prevention trial, J Alzheimers Dis, 36(3), 433-43. En savoir plus.

Rive B., Gauthier S., Costello S., Marre C., Francois C. (2013). Synthesis and comparison of the meta-analyses evaluating the efficacy of memantine in moderate to severe stages of Alzheimer's disease, CNS Drugs, 27(7), 573-82. En savoir plus.

Rosa-Neto P., Hsiung G. Y., Masellis M. (2013). Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians, Alzheimers Res Ther, 5(Suppl 1), S8. En savoir plus.

Rowley J., Fonov V., Wu O., Eskildsen S. F., Schoemaker D., Wu L., Mohades S., Shin M., Sziklas V., Cheewakriengkrai L., Shmuel A., Dagher A., Gauthier S., Rosa-Neto P., Alzheimer's Disease Neuroimaging Initiative (2013). White matter abnormalities and structural hippocampal disconnections in amnestic mild cognitive impairment and Alzheimer's disease, PLoS One, 8(9), e74776. En savoir plus.

Schilling L. P., Kieling R. R., Pascoal T. A., Kim H. I., Lee M. C., Kim Y. H., Paglioli E., Rosa-Neto P., Costa J. C., Palmini A. (2013). Bilateral perisylvian ulegyria: an under-recognized, surgically remediable epileptic syndrome, Epilepsia, 54(8), 1360-7. En savoir plus.

Schwabe L., Nader K., Pruessner J. (2013). beta-Adrenergic blockade during reactivation reduces the subjective feeling of remembering associated with emotional episodic memories, Biol Psychol, 92(2), 227-32. En savoir plus.

Seifert C. L., Chakravarty M., Sprenger T. (2013). The complexities of pain after stroke--a review with a focus on central post-stroke pain, Panminerva Med, 55(1), 1-10. En savoir plus.

Shukla M., Quirion R., Ma W. (2013). Reduced expression of pain mediators and pain sensitivity in amyloid precursor protein over-expressing CRND8 transgenic mice, Neuroscience. En savoir plus.